2014-09-03 21:32:53 UTC

Gastroenterology Podcast September 2014: Vedolizumab for Crohn’s Patients After TNF Therapy Has Failed

A study in the September issue of Gastroenterology evaluated the effects of vedolizumab induction therapy for patients with Crohn’s disease for whom tumor necrosis factor (TNF) antagonists have already failed. Dr. Kuemmerle speaks with the first author of the study, Dr. Bruce E. Sands of the Ichan School of Medicine at Mount Sinai, New York; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

 

 

Sands BE, Feagan BG, Rutgeerts P, et al. Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed. Gastroenterology 2014; September; 147(3): 618–627.e3
Abstract

 

 

Duration: 16.54m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

More on Crohn's Disease

Crohn's & Colitis Congress™

Jan. 18, 2018

The Crohn's & Colitis Foundation and AGA are partnering on a new annual conference for health-care professionals and researchers. By joining the nation's leading IBD patient organization with the premier gastroenterological professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.

Digestive Disease Week® (DDW)

May 6, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

IBD 114: Managing Crohn's Disease after Surgery

March 31, 2017

Learn more about Managing Crohn's Disease After Surgery, based on the AGA Clinical Guideline "Management of Crohn's Disease After Surgical Resection."